J&J Medical Connect
Immunology
Immunology

Congress Materials – European Chron's and Colitis Organization (ECCO 2026)

 

2026 European Crohn's & Colitis Organization Congress | Feb 18-20 | Stockholm, Sweden

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses.  Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

 

Extraintestinal Manifestations in Participants with Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GALAXI 2 & 3 Studies

Silvio Danese, Tadakazu Hisamatsu, Rian Van Rampelbergh, Wilbert van Duijnhoven, Gustavo Scapini, Shashi Adsul, David T. Rubin


View presentation slides

 

Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.